Keyphrases
C1 Esterase Inhibitor
100%
Angioedema Attack
100%
Hereditary Angioedema
100%
C1 Inhibitor
100%
Adverse Events
87%
Injection Site Reaction
75%
Sepsis
25%
Bacteremia
25%
Twice Daily
25%
Inhibitory Antibody
25%
Clinically Significant
12%
Tolerability
12%
Placebo
12%
Dose Effect
12%
Safety Concerns
12%
U.S. Food
12%
Laboratory Assessment
12%
Optimal Management
12%
Serious Adverse Events
12%
Treatment Discontinuation
12%
Dosing Regimen
12%
Thrombotic
12%
Angioedema
12%
Low Volume
12%
Anaphylaxis
12%
Non-serious
12%
E-diary
12%
C1-inhibitor Replacement Therapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Angioneurotic Edema
100%
Complement Component C1s Inhibitor
100%
Adverse Event
80%
Injection Site Reaction
60%
Thromboembolism
20%
Sepsis
20%
Bacteremia
20%
Anaphylaxis
20%
Placebo
10%
Tolerability
10%
Erethism
10%
Clinical Study
10%
Replacement Therapy
10%
Subcutaneous Injection
10%